Access cutting-edge glioma treatment through this clinical trial at a research site in Hartford. Study-provided care at no cost to qualified participants.
Access glioma specialists in Hartford at no cost
This study follows strict safety protocols and ethical guidelines
All study-related glioma treatment provided free
This study will test the safety and effectiveness of a combination of pembrolizumab, olaparib, and temozolomide to see how well these drugs work when given together in people with a glioma that either did not respond to previous treatment or came back after treatment.
Sponsor: Memorial Sloan Kettering Cancer Center
Check if you qualify for this glioma clinical trial in Hartford, CT
If you're searching for glioma treatment options in Hartford, CT, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Hartford research site is actively enrolling participants for this clinical trial. You'll receive care from experienced glioma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.